Howe, Zachary <br/><br/>
Bleeding rates of Veterans taking apixaban or rivaroxaban for atrial fibrillation or venous thromboembolism.  [electronic resource] 

 -  Journal of thrombosis and thrombolysis  Feb 2019 
 - 280-286 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1573-742X 
<br/><br/><label>Standard No.: </label>10.1007/s11239-018-1770-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Aged, 80 and over<br/>Atrial Fibrillation--blood<br/>Blood Coagulation--drug effects<br/>Factor Xa Inhibitors--administration & dosage<br/>Female<br/>Hemorrhage--chemically induced<br/>Humans<br/>Male<br/>Middle Aged<br/>Pyrazoles--administration & dosage<br/>Pyridones--administration & dosage<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Rivaroxaban--administration & dosage<br/>Time Factors<br/>Treatment Outcome<br/>United States--epidemiology<br/>United States Department of Veterans Affairs<br/>Venous Thromboembolism--blood<br/>Veterans Health